You are now leaving GSK’s website

You are now leaving a GSK Website. By clicking this link, you will be taken to a website that is not owned or controlled by GSK, and GSK is not responsible for the content provided on that site


Go back


Volibris is a once daily treatment for adult patients with pulmonary arterial hypertension (PAH), classified as WHO Functional Class (FC) II to III to improve exercise ability. 1


  1. Volibris Singapore Prescribing Information

Volibris is a registered trademark of Gilead Sciences, Inc., used under licence by the GSK group of companies

All images used are for illustration purposes only.